Brophebarbital

Brophebarbital is a barbiturate derivative that was developed in the early 20th century. It is known for its sedative and hypnotic properties, which make it useful in the treatment of insomnia and other sleep disorders. Brophebarbital is chemically related to other barbiturates such as phenobarbital and pentobarbital.
Chemical Structure and Properties[edit]
Brophebarbital belongs to the class of organic compounds known as barbiturates. These compounds are derivatives of barbituric acid and are characterized by their ability to depress the central nervous system. The chemical structure of brophebarbital includes a pyrimidine ring, which is a common feature of barbiturates.
Pharmacology[edit]
Brophebarbital acts on the gamma-aminobutyric acid (GABA) receptor, enhancing the effect of the neurotransmitter GABA. This action results in increased inhibitory neurotransmission, leading to sedation and hypnosis. The drug has a relatively long half-life, which makes it effective for maintaining sleep throughout the night.
Medical Uses[edit]
Brophebarbital is primarily used for its sedative and hypnotic effects. It is prescribed for the short-term treatment of insomnia and is sometimes used as a pre-anesthetic agent. Due to its potential for dependence and tolerance, it is generally recommended for short-term use only.
Side Effects and Risks[edit]
Common side effects of brophebarbital include drowsiness, dizziness, and headache. More serious side effects can include respiratory depression, hypotension, and allergic reactions. Long-term use can lead to dependence and withdrawal symptoms upon discontinuation.
Regulation and Legal Status[edit]
Brophebarbital, like other barbiturates, is a controlled substance in many countries due to its potential for abuse and dependence. It is classified under various schedules depending on the jurisdiction.
History[edit]
Brophebarbital was first synthesized in the early 20th century as part of the search for new sedative and hypnotic agents. It was one of many barbiturates developed during this period, which also saw the introduction of other well-known compounds such as phenobarbital and secobarbital.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian